Natick machine vision firm Cognex has named a new CEO and president, following the retirement of the $915-million public company’s longtime leader, Robert Willett.
Massachusetts experienced a more than 36% decrease in opioid-related overdose deaths in 2024, the state Substance Addiction Services Bureau reported Wednesday.
After months of negotiations, including those with an anonymous, unsolicited third party, Marlborough-based biotech firm Akoya Biosciences has officially been acquired by Quanterix.
In the latest addition in the extensive C-suite overhaul at Definitive Healthcare, the Framingham health data and technology firm has decided to eliminate its chief operating officer position.
Labor unions rallied at the State House on Tuesday against legislation that would usher driverless cars into Massachusetts as industry voices touted the vehicles' safety and efficiency just hours later.
Harvard Bioscience, a Holliston-based biotech firm, has fallen out of compliance with Nasdaq stock exchange requirements following the resignation of a board of directors member.
As artificial intelligence expands its presence within health care, UMass Chan Medical School in Worcester has partnered with a Virginia-based incubator to evaluate AI products to promote innovation and establish guidelines for AI deployment in patient care.